Exact Sciences (EXAS) Payables (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Payables data on file, last reported at $175.9 million in Q4 2025.

• Payables for Q4 2025 came in at $175.9 million, down 48.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $175.9 million (down 48.08% YoY), and the FY2025 annual result was $175.9 million, down 48.08% from the prior year.
• Payables grew to $175.9 million in Q4 2025 per EXAS's latest filing, from $129.4 million in the prior quarter.
• Over five years, Payables peaked at $349.6 million in Q2 2021 and troughed at $36.0 million in Q1 2021.
• A 5-year average of $150.1 million and a median of $85.4 million in 2022 frame the typical range for Payables.
• The sharpest annual moves came in 2021 and 2022: Payables surged 981.64% in 2021, then sank 75.92% in 2022.
• A 5-year view of Payables shows it stood at $67.8 million in 2021, then grew by 10.45% to $74.9 million in 2022, then climbed by 5.21% to $78.8 million in 2023, then surged by 329.77% to $338.7 million in 2024, then tumbled by 48.08% to $175.9 million in 2025.
• Business Quant data shows EXAS's Payables at $175.9 million in Q4 2025, $129.4 million in Q3 2025, and $157.3 million in Q2 2025.